Kankadeb Mishra

680 citations
7 papers · 245 indexed · h-index 7
Topics
RNA modifications and cancer (4 papers)Cancer-related molecular mechanisms research (3 papers)RNA Research and Splicing (3 papers)
Partner nations
SwedenUnited StatesItaly

In The Last Decade

Kankadeb Mishra

7 papers receiving 243 citations

Peers

Kankadeb Mishra
Comparison fields: 5 of 35
  • Molecular Biology 196
  • Cancer Research 128
  • Genetics 67
  • Pediatrics, Perinatology and Child Health 40
  • Immunology 21
Replace Michael Hinten with:
Michael Hinten United States
Chenghua Cui China
Junbin Liang China
Lars Schomacher Germany
Chris Small United States
Brittany S. Sexton United States
Shoufang Qu China
Congjian Xu China
Bridget Shaner United States
Lorraine Bonneville France
Kankadeb Mishra relative to Michael Hinten United States Michael Hinten's profile →
Citations per field
00.5×1.5×2.2×
Michael Hinten · 1×
Citations per year

Countries citing papers authored by Kankadeb Mishra

Since Specialization
Citations

This map shows the geographic impact of Kankadeb Mishra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kankadeb Mishra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kankadeb Mishra more than expected).

Fields of papers citing papers by Kankadeb Mishra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kankadeb Mishra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kankadeb Mishra. The network helps show where Kankadeb Mishra may publish in the future.

Co-authorship network of co-authors of Kankadeb Mishra

This figure shows the co-authorship network connecting the top 25 collaborators of Kankadeb Mishra. A scholar is included among the top collaborators of Kankadeb Mishra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kankadeb Mishra. Kankadeb Mishra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 18
2 6
3 78
4 22
5 10
6 98
7 13

About Kankadeb Mishra

Kankadeb Mishra is a scholar working on Cancer Research, Genetics and Hematology, having authored 7 papers that have together received 245 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Biology (196 citations) and Genetics (67 citations). Kankadeb Mishra has collaborated with scholars based in Sweden, United States and Italy. Frequent co-authors include Chandrasekhar Kanduri, Meena Kanduri, Massimo Carella, Andrea Riccio, Alessandro Mussa, Margherita Silengo, Orazio Palumbo, Agostina De Crescenzo, Angela Sparago and Elisabetta Lapi. Their work appears in journals such as Nucleic Acids Research, Oncogene and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026